Evaluating Nevro: Insights From 8 Financial Analysts
Portfolio Pulse from Benzinga Insights
In the latest quarter, 8 analysts provided ratings for Nevro (NYSE: NVRO), showing a mix of bullish and bearish perspectives. The average 12-month price target is now $7.96, down from $12.44. Analysts from firms like RBC Capital, Baird, and Wells Fargo have lowered their ratings and price targets for Nevro. The company has shown a revenue growth rate of 5.78% over the past three months but lags behind industry peers. Nevro's net margin, ROE, and ROA are negative, but it has a below-average debt-to-equity ratio of 0.78.
August 07, 2024 | 6:04 pm
News sentiment analysis
Sort by:
Descending
NEGATIVE IMPACT
Analysts have mixed sentiments about Nevro (NYSE: NVRO), with a lowered average 12-month price target of $7.96. The company has shown positive revenue growth but lags behind industry peers. Key financial metrics like net margin, ROE, and ROA are negative, but the debt-to-equity ratio is below average.
The majority of analysts have lowered their ratings and price targets for Nevro, indicating a bearish outlook. Despite positive revenue growth, the company lags behind its peers, and key financial metrics are negative. This suggests a likely short-term decline in stock price.
CONFIDENCE 95
IMPORTANCE 90
RELEVANCE 100